BNTC icon

Benitec Biopharma
BNTC

Overview Fund Activity

25 hedge funds and large institutions have $5.92M invested in Benitec Biopharma in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Franklin Resources
1
Franklin Resources
California
$3.72M
2
AC
2
Armistice Capital
New York
$578K
3
CH
3
CVI Holdings
Delaware
$479K
4
EAM
4
Empery Asset Management
New York
$296K
5
ACM
5
Altium Capital Management
New York
$245K

Top Sellers

1
Barclays
1
Barclays
United Kingdom
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
VF
4
Virtu Financial
New York
$0
5
TSS
5
Two Sigma Securities
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TSS
26
Two Sigma Securities
New York
– – -24,270 Closed
Simplex Trading
27
Simplex Trading
Illinois
$0 100 -6,099 -98%
Citigroup
28
Citigroup
New York
– – -3,440 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
Rockefeller Capital Management
30
Rockefeller Capital Management
New York
$0 300 – –
Wells Fargo
31
Wells Fargo
California
$0 52 +5 +11%
CG
32
Cutler Group
California
$0 1,000 +1,000 New
1
2